ATF2 (fosfo Thr73 / 55) Antilichaam

Transcriptional activator, probably constitutive, which binds to the cAMP-responsive element (CRE) (consensus: 5'-GTGACGT[AC][AG]-3'), a sequence present in many viral and cellular promoters. Interaction with JUN redirects JUN to bind to CRES preferentially over the 12-O-tetradecanoylphorbol-13-acetate response elements (TRES) as part of an ATF2-c-Jun complex.

1386

P15336

NP_001871.2

Human, Mouse, Rat

ATF2 (Phospho-Thr73 or 55) antibody was raised against a peptide sequence around phosphorylation site of threonine 73 or 55 (T-P-T (p) -R-F) derived from Human ATF2.

Unconjugated

Primary Antibodies

Phospho-Specific

Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy using non-phosphopeptide.

1 mg/mL

Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

Phospho-Specific

Blue Ice

Store antibody at -20˚ C for up to one year.

65 - 75 kDa

This antibody detects endogenous level of ATF-2 only whenphosphorylated at threonine 73 or 55.

Western Blot: 1:500~1:1000, Immunohistochemistry: 1:50~1:100, Immunofluorescence: 1:100~1:200

ATF2

Activating transcription factor 2

Homo sapiens

Beausoleil S A, et al. (2004) Proc Natl Acad Sci U S A. 101 (33) : 12130-12135. Abdel-Hafiz H A, et al. (1992) Mol Endocrinol. 6: 2079-2089. Gupta S, et al. (1995) Science. 267: 389-393. Van Dam H, et al. (1995) EMBO J. 14 (8) : 1798-1811. Livingstone C, et al. (1995) EMBO J. 14: 1785-1797.

HB16, CREB2, TREB7, CREB-2, CRE-BP1, APRF, CREBP1

WB, IHC, IF

22538422

Liquid